Showing 1 - 4 results of 4 for search 'Susan Pederson', query time: 0.02s Refine Results
  1. 1
    Tolerability of eptinezumab in overweight, obese or type 1 diabetes patients

    Tolerability of eptinezumab in overweight, obese or type 1 diabetes patients by Brian Baker, Barbara Schaeffler, Joe Hirman, Marcus Hompesch, Susan Pederson, Jeff Smith

    Published 2021-04-01
    Get full text
    Article
  2. 2
    Clinical Immunogenicity Evaluation of Eptinezumab, a Therapeutic Humanized Monoclonal Antibody Targeting Calcitonin Gene-Related Peptide (CGRP) for the Preventive Treatment of Migraine

    Clinical Immunogenicity Evaluation of Eptinezumab, a Therapeutic Humanized Monoclonal Antibody Targeting Calcitonin Gene-Related Peptide (CGRP) for the Preventive Treatment of Migr... by Susan Pederson, David M. Biondi, Brent Allan, Roger Cady, Barbara Schaeffler, Brian Baker, John Latham

    Published 2021-10-01
    Get full text
    Article
  3. 3
    Population pharmacokinetic and exposure‐response analysis of eptinezumab in the treatment of episodic and chronic migraine

    Population pharmacokinetic and exposure‐response analysis of eptinezumab in the treatment of episodic and chronic migraine by Brian Baker, Barbara Schaeffler, Martin Beliveau, Igor Rubets, Susan Pederson, MyMy Trinh, Jeff Smith, John Latham

    Published 2020-04-01
    Get full text
    Article
  4. 4
    Eptinezumab for the prevention of chronic migraine: efficacy and safety through 24 weeks of treatment in the phase 3 PROMISE-2 (Prevention of migraine via intravenous ALD403 safety and efficacy–2) study

    Eptinezumab for the prevention of chronic migraine: efficacy and safety through 24 weeks of treatment in the phase 3 PROMISE-2 (Prevention of migraine via intravenous ALD403 safety... by Stephen Silberstein, Merle Diamond, Nada A. Hindiyeh, David M. Biondi, Roger Cady, Joe Hirman, Brent Allan, Susan Pederson, Barbara Schaeffler, Jeff Smith

    Published 2020-10-01
    Get full text
    Article

Search Tools: